PsiOxus Will Seek $50m Series D Financing In H1 2018 To Fund Pipeline
PsiOxus Therapeutics' CEO tells Scrip it will seek the fresh funding next year to progress its pipeline which aims to treat solid tumors through systemic delivery of oncolytic viruses.